UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
Rhea-AI Summary
UFP Technologies (Nasdaq: UFPT) will report fourth quarter and year-end 2025 results on February 24, 2026 after market close and host a conference call on February 25, 2026 at 8:30 AM ET.
Investors may join via the provided toll-free numbers or a live webcast; a replay will be available on the company’s Investor Relations website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, UFPT declined 5.87%, reflecting a notable negative market reaction. Argus tracked a trough of -8.7% from its starting point during tracking. Our momentum scanner triggered 26 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $113M from the company's valuation, bringing the market cap to $1.82B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
UFPT fell -5.87% while key medical device peers like CNMD (+3.61%), ENOV (+2.22%), and IART (+4.44%) rose. Momentum data shows only one peer (BBNX, -5.62%) also moving down and without news, supporting a stock-specific move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 02 | CEO succession plan | Neutral | -1.1% | Outlined June 2026 CEO transition with outgoing CEO as Executive Chairman. |
| Nov 25 | Investor conference | Neutral | -2.2% | Announced participation and 1x1 meetings at Piper Sandler healthcare conference. |
| Nov 03 | Q3 2025 earnings | Positive | +3.3% | Reported strong Q3 sales growth and higher year-to-date net income. |
| Oct 29 | Q3 results date | Neutral | -4.3% | Set November 3, 2025 Q3 release and November 4 conference call details. |
| Aug 20 | IDEAS conference | Neutral | +0.9% | Announced presentation at Midwest IDEAS conference and access details for investors. |
Recent company news, including strong Q3 2025 earnings, has generally seen modest price reactions, with the one prior earnings-date announcement followed by a noticeable but not extreme pullback.
Over the past six months, UFPT has reported strong Q3 2025 results with higher sales and steady earnings, announced a planned CEO succession effective June 4, 2026, and remained visible at investor conferences. A prior earnings-date notice in late October 2025 preceded a short-term decline, while the subsequent Q3 earnings release saw a positive reaction. Today’s year-end 2025 earnings-date announcement fits this pattern of regular, scheduled communication with modest but sometimes volatile price responses.
Market Pulse Summary
The stock moved -5.9% in the session following this news. A negative reaction despite this being only an earnings-date announcement fits prior instances where scheduling news preceded volatility, such as the October 2025 results-date notice followed by a -4.31% move. The stock already traded above its 200-day MA, so weakness emerged from a relatively strong technical base. With short interest around 11.54% and days to cover at 6.38, positioning could have amplified selling pressure around upcoming results.
AI-generated analysis. Not financial advice.
Conference Call Scheduled for February 25th at 8:30 AM ET
NEWBURYPORT, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the fourth quarter and year-end on Tuesday, February 24th, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, February 25th, at 8:30 AM Eastern time.
Conference Call Information:
Date: Wednesday, February 25, 2026
Time: 8:30 AM Eastern Time
Participants may join the call using the following dial-in numbers:
- USA/Canada: Toll-Free: 1-412-206-6478
- International: 1-833-890-4010
A live webcast of the conference call and accompanying materials will be available here.
A replay of the webcast will be accessible following the event on the Company’s Investor Relations website at https://ufpt.com/investors/.
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Investor Contact:
Jeff Elliott
Three Part Advisors, LLC
214-966-9014
UFP Technologies Contact:
Ron Lataille, CFO
978-234-0926
rlataille@ufpt.com
FAQ
When will UFP Technologies (UFPT) release Q4 and year-end 2025 results?
How can investors join the UFPT conference call on February 25, 2026?
What time is the UFPT investor webcast scheduled for February 25, 2026?
Will UFPT provide a replay of the February 25, 2026 earnings call?
What dial-in numbers should I use for the UFPT February 25, 2026 conference call?
